Silvestris, Nicola <br/><br/>
Target therapies in pancreatic carcinoma.  [electronic resource] 

 -  Current medicinal chemistry  2014 
 - 948-65 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1875-533X 
<br/><br/><label>Standard No.: </label>10.2174/09298673113209990238  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Albumins--therapeutic use<br/>Animals<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Bevacizumab<br/>ErbB Receptors--antagonists & inhibitors<br/>Erlotinib Hydrochloride<br/>Hedgehog Proteins--antagonists & inhibitors<br/>Humans<br/>Matrix Metalloproteinases--metabolism<br/>Molecular Targeted Therapy--methods<br/>Paclitaxel--therapeutic use<br/>Pancreas--drug effects<br/>Pancreatic Neoplasms--drug therapy<br/>Quinazolines--therapeutic use<br/>Receptor, IGF Type 1--antagonists & inhibitors<br/>Signal Transduction--drug effects